These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7627951)

  • 41. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles.
    Stano A; Scott EA; Dane KY; Swartz MA; Hubbell JA
    Biomaterials; 2013 Jun; 34(17):4339-46. PubMed ID: 23478034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of antigen-specific class I-restricted cytotoxic T cells by soluble proteins in vivo.
    Raychaudhuri S; Tonks M; Carbone F; Ryskamp T; Morrow WJ; Hanna N
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8308-12. PubMed ID: 1518862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD4+ but not CD8+ T cells are required for the induction of oral tolerance.
    Garside P; Steel M; Liew FY; Mowat AM
    Int Immunol; 1995 Mar; 7(3):501-4. PubMed ID: 7794826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD8+ T-cell mediated tumor protection by Pseudomonas exotoxin fused to ovalbumin in C57BL/6 mice.
    Becerra JC; Arthur JF; Landucci GR; Forthal DN; Theuer CP
    Surgery; 2003 Apr; 133(4):404-10. PubMed ID: 12717358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes.
    Nakagawa Y; Negishi Y; Shimizu M; Takahashi M; Ichikawa M; Takahashi H
    Immunol Lett; 2015 Oct; 167(2):72-86. PubMed ID: 26209187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of antigen expression from plasmid DNA in tumor-free and antigen-expressing tumor-bearing mice.
    Guan X; Guan X; Nishikawa M; Nishikawa M; Li H; Li H; Rei T; Rei T; Takahashi Y; Takahashi Y; Takakura Y; Takakura Y
    Hum Vaccin Immunother; 2012 Feb; 8(2):194-200. PubMed ID: 22426379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses.
    Del Pozzo G; Mascolo D; Sartorius R; Citro A; Barba P; D'Apice L; De Berardinis P
    J Biomed Biotechnol; 2010; 2010():894971. PubMed ID: 20454650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unexpectedly, induction of cytotoxic T lymphocytes enhances the humoral response after DNA immunization.
    Dyer CM; Zhan Y; Brady JL; Carbone FR; Smyth MJ; Lew AM
    Blood; 2004 Apr; 103(8):3073-5. PubMed ID: 15070687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced anti-tumor immunotherapy by dissolving microneedle patch loaded ovalbumin.
    Lee SJ; Lee HS; Hwang YH; Kim JJ; Kang KY; Kim SJ; Kim HK; Kim JD; Jeong DH; Paik MJ; Yee ST
    PLoS One; 2019; 14(8):e0220382. PubMed ID: 31386690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanism of the induction of anti-tumor immunity by B7.1 and interleukin-12.
    Wysocka M; Coughlin CM; Kurzawa HL; Trinchieri G; Eck SL; Lee WM
    Ann N Y Acad Sci; 1996 Oct; 795():429-33. PubMed ID: 8958975
    [No Abstract]   [Full Text] [Related]  

  • 51. A polymeric conjugate foreignizing tumor cells for targeted immunotherapy in vivo.
    Lee YH; Yoon HY; Shin JM; Saravanakumar G; Noh KH; Song KH; Jeon JH; Kim DW; Lee KM; Kim K; Kwon IC; Park JH; Kim TW
    J Control Release; 2015 Feb; 199():98-105. PubMed ID: 25499555
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracellular
    Raman V; Howell LM; Bloom SMK; Hall CL; Wetherby VE; Minter LM; Kulkarni AA; Forbes NS
    Front Immunol; 2023; 14():1228532. PubMed ID: 37868996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Kinetics of in vivo tumor cell destruction after specific immunization.
    Orbach-Arbouys S; Bravo-Cuellar A; Lhéritier J
    Anticancer Res; 1989; 9(1):97-101. PubMed ID: 2705762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporin A/VP-16 produced immunity to L1210 leukemia: the participation of cytotoxic CD8 T-lymphocytes.
    Slater LM; Sweet P; Stupecky M; Reynolds JT
    Clin Immunol Immunopathol; 1995 Jun; 75(3):239-45. PubMed ID: 7768041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiphoton imaging of cytotoxic T lymphocyte-mediated antitumor immune responses.
    Boissonnas A; Scholer-Dahire A; Fetler L; Amigorena S
    Curr Top Microbiol Immunol; 2009; 334():265-87. PubMed ID: 19521689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo.
    Black M; Trent A; Kostenko Y; Lee JS; Olive C; Tirrell M
    Adv Mater; 2012 Jul; 24(28):3845-9. PubMed ID: 22550019
    [No Abstract]   [Full Text] [Related]  

  • 57. Tumor cell vaccination for gynecological tumors.
    Möbus V; Horn S; Stöck M; Schirrmacher V
    Hybridoma; 1993 Oct; 12(5):543-7. PubMed ID: 7905460
    [No Abstract]   [Full Text] [Related]  

  • 58. A role for anaphylactic sensitization in tumor control.
    Correnti M; Sánchez M; Suárez Chacón R
    Int Arch Allergy Appl Immunol; 1985; 76(1):20-4. PubMed ID: 3967928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tumor immunology].
    Klein G
    Nord Med; 1967 Jun; 77(25):789-97. PubMed ID: 6026866
    [No Abstract]   [Full Text] [Related]  

  • 60. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice.
    Maeda H; Shiraishi A
    J Immunol; 1996 Jan; 156(1):73-8. PubMed ID: 8598496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.